nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Thiotepa—sarcoma	0.105	0.458	CbGbCtD
Paricalcitol—CYP3A4—Mitoxantrone—sarcoma	0.0452	0.197	CbGbCtD
Paricalcitol—VDR—periosteum—sarcoma	0.0379	0.15	CbGeAlD
Paricalcitol—CYP3A4—Vincristine—sarcoma	0.0311	0.136	CbGbCtD
Paricalcitol—VDR—leg—sarcoma	0.0302	0.12	CbGeAlD
Paricalcitol—VDR—forelimb—sarcoma	0.03	0.119	CbGeAlD
Paricalcitol—CYP3A4—Etoposide—sarcoma	0.0285	0.124	CbGbCtD
Paricalcitol—VDR—hindlimb—sarcoma	0.027	0.107	CbGeAlD
Paricalcitol—VDR—appendage—sarcoma	0.0232	0.0917	CbGeAlD
Paricalcitol—CYP3A4—Doxorubicin—sarcoma	0.0195	0.0847	CbGbCtD
Paricalcitol—CYP24A1—seminal vesicle—sarcoma	0.0131	0.052	CbGeAlD
Paricalcitol—UGT1A4—hematopoietic system—sarcoma	0.0125	0.0494	CbGeAlD
Paricalcitol—CYP24A1—hematopoietic system—sarcoma	0.0125	0.0494	CbGeAlD
Paricalcitol—VDR—mammary gland—sarcoma	0.0113	0.0446	CbGeAlD
Paricalcitol—VDR—hematopoietic system—sarcoma	0.00686	0.0272	CbGeAlD
Paricalcitol—VDR—connective tissue—sarcoma	0.00661	0.0262	CbGeAlD
Paricalcitol—UGT1A4—liver—sarcoma	0.00646	0.0256	CbGeAlD
Paricalcitol—VDR—skin of body—sarcoma	0.00597	0.0236	CbGeAlD
Paricalcitol—VDR—uterus—sarcoma	0.00519	0.0205	CbGeAlD
Paricalcitol—VDR—lymphoid tissue—sarcoma	0.00483	0.0191	CbGeAlD
Paricalcitol—VDR—tendon—sarcoma	0.00454	0.018	CbGeAlD
Paricalcitol—VDR—bone marrow—sarcoma	0.0044	0.0174	CbGeAlD
Paricalcitol—VDR—testis—sarcoma	0.00376	0.0149	CbGeAlD
Paricalcitol—VDR—lymph node—sarcoma	0.00273	0.0108	CbGeAlD
Paricalcitol—CYP3A4—hematopoietic system—sarcoma	0.00229	0.00909	CbGeAlD
Paricalcitol—CYP3A4—liver—sarcoma	0.00119	0.00471	CbGeAlD
Paricalcitol—Gastritis—Epirubicin—sarcoma	0.000772	0.00149	CcSEcCtD
Paricalcitol—Confusional state—Etoposide—sarcoma	0.000772	0.00149	CcSEcCtD
Paricalcitol—Cardiac arrest—Doxorubicin—sarcoma	0.000768	0.00148	CcSEcCtD
Paricalcitol—Asthenia—Thiotepa—sarcoma	0.000764	0.00148	CcSEcCtD
Paricalcitol—Infection—Etoposide—sarcoma	0.00076	0.00147	CcSEcCtD
Paricalcitol—Asthenia—Dactinomycin—sarcoma	0.000759	0.00146	CcSEcCtD
Paricalcitol—Feeling abnormal—Mitoxantrone—sarcoma	0.000758	0.00146	CcSEcCtD
Paricalcitol—Influenza—Epirubicin—sarcoma	0.000754	0.00146	CcSEcCtD
Paricalcitol—Asthma—Epirubicin—sarcoma	0.000754	0.00146	CcSEcCtD
Paricalcitol—Dysphagia—Epirubicin—sarcoma	0.000754	0.00146	CcSEcCtD
Paricalcitol—Pruritus—Thiotepa—sarcoma	0.000754	0.00146	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000752	0.00145	CcSEcCtD
Paricalcitol—Dehydration—Doxorubicin—sarcoma	0.000751	0.00145	CcSEcCtD
Paricalcitol—Body temperature increased—Vincristine—sarcoma	0.000747	0.00144	CcSEcCtD
Paricalcitol—Abdominal pain—Vincristine—sarcoma	0.000747	0.00144	CcSEcCtD
Paricalcitol—Skin disorder—Etoposide—sarcoma	0.000743	0.00144	CcSEcCtD
Paricalcitol—Hyperhidrosis—Etoposide—sarcoma	0.00074	0.00143	CcSEcCtD
Paricalcitol—Pancreatitis—Epirubicin—sarcoma	0.00074	0.00143	CcSEcCtD
Paricalcitol—Urticaria—Mitoxantrone—sarcoma	0.000731	0.00141	CcSEcCtD
Paricalcitol—Breast disorder—Doxorubicin—sarcoma	0.00073	0.00141	CcSEcCtD
Paricalcitol—Anorexia—Etoposide—sarcoma	0.000729	0.00141	CcSEcCtD
Paricalcitol—Diarrhoea—Thiotepa—sarcoma	0.000729	0.00141	CcSEcCtD
Paricalcitol—Body temperature increased—Mitoxantrone—sarcoma	0.000727	0.0014	CcSEcCtD
Paricalcitol—Abdominal pain—Mitoxantrone—sarcoma	0.000727	0.0014	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000727	0.0014	CcSEcCtD
Paricalcitol—Diarrhoea—Dactinomycin—sarcoma	0.000723	0.0014	CcSEcCtD
Paricalcitol—Nasopharyngitis—Doxorubicin—sarcoma	0.000722	0.00139	CcSEcCtD
Paricalcitol—Hypotension—Etoposide—sarcoma	0.000715	0.00138	CcSEcCtD
Paricalcitol—Gastritis—Doxorubicin—sarcoma	0.000715	0.00138	CcSEcCtD
Paricalcitol—Dizziness—Thiotepa—sarcoma	0.000704	0.00136	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Epirubicin—sarcoma	0.000701	0.00135	CcSEcCtD
Paricalcitol—Asthma—Doxorubicin—sarcoma	0.000698	0.00135	CcSEcCtD
Paricalcitol—Influenza—Doxorubicin—sarcoma	0.000698	0.00135	CcSEcCtD
Paricalcitol—Dysphagia—Doxorubicin—sarcoma	0.000698	0.00135	CcSEcCtD
Paricalcitol—Hypersensitivity—Vincristine—sarcoma	0.000696	0.00134	CcSEcCtD
Paricalcitol—Paraesthesia—Etoposide—sarcoma	0.000687	0.00133	CcSEcCtD
Paricalcitol—Pancreatitis—Doxorubicin—sarcoma	0.000684	0.00132	CcSEcCtD
Paricalcitol—Weight decreased—Epirubicin—sarcoma	0.000682	0.00132	CcSEcCtD
Paricalcitol—Dyspnoea—Etoposide—sarcoma	0.000682	0.00132	CcSEcCtD
Paricalcitol—Somnolence—Etoposide—sarcoma	0.00068	0.00131	CcSEcCtD
Paricalcitol—Hypersensitivity—Mitoxantrone—sarcoma	0.000678	0.00131	CcSEcCtD
Paricalcitol—Asthenia—Vincristine—sarcoma	0.000678	0.00131	CcSEcCtD
Paricalcitol—Vomiting—Thiotepa—sarcoma	0.000677	0.00131	CcSEcCtD
Paricalcitol—Pneumonia—Epirubicin—sarcoma	0.000676	0.00131	CcSEcCtD
Paricalcitol—Infestation NOS—Epirubicin—sarcoma	0.000673	0.0013	CcSEcCtD
Paricalcitol—Infestation—Epirubicin—sarcoma	0.000673	0.0013	CcSEcCtD
Paricalcitol—Vomiting—Dactinomycin—sarcoma	0.000672	0.0013	CcSEcCtD
Paricalcitol—Rash—Thiotepa—sarcoma	0.000672	0.0013	CcSEcCtD
Paricalcitol—Dermatitis—Thiotepa—sarcoma	0.000671	0.0013	CcSEcCtD
Paricalcitol—Headache—Thiotepa—sarcoma	0.000667	0.00129	CcSEcCtD
Paricalcitol—Rash—Dactinomycin—sarcoma	0.000667	0.00129	CcSEcCtD
Paricalcitol—Decreased appetite—Etoposide—sarcoma	0.000665	0.00128	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Etoposide—sarcoma	0.000661	0.00128	CcSEcCtD
Paricalcitol—Asthenia—Mitoxantrone—sarcoma	0.00066	0.00127	CcSEcCtD
Paricalcitol—Fatigue—Etoposide—sarcoma	0.00066	0.00127	CcSEcCtD
Paricalcitol—Pain—Etoposide—sarcoma	0.000654	0.00126	CcSEcCtD
Paricalcitol—Constipation—Etoposide—sarcoma	0.000654	0.00126	CcSEcCtD
Paricalcitol—Urinary tract infection—Epirubicin—sarcoma	0.000654	0.00126	CcSEcCtD
Paricalcitol—Conjunctivitis—Epirubicin—sarcoma	0.000654	0.00126	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000649	0.00125	CcSEcCtD
Paricalcitol—Diarrhoea—Vincristine—sarcoma	0.000646	0.00125	CcSEcCtD
Paricalcitol—Sweating—Epirubicin—sarcoma	0.000645	0.00124	CcSEcCtD
Paricalcitol—Epistaxis—Epirubicin—sarcoma	0.000634	0.00122	CcSEcCtD
Paricalcitol—Nausea—Thiotepa—sarcoma	0.000633	0.00122	CcSEcCtD
Paricalcitol—Weight decreased—Doxorubicin—sarcoma	0.000631	0.00122	CcSEcCtD
Paricalcitol—Sinusitis—Epirubicin—sarcoma	0.000631	0.00122	CcSEcCtD
Paricalcitol—Feeling abnormal—Etoposide—sarcoma	0.000631	0.00122	CcSEcCtD
Paricalcitol—Diarrhoea—Mitoxantrone—sarcoma	0.000629	0.00122	CcSEcCtD
Paricalcitol—Nausea—Dactinomycin—sarcoma	0.000628	0.00121	CcSEcCtD
Paricalcitol—Pneumonia—Doxorubicin—sarcoma	0.000626	0.00121	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Etoposide—sarcoma	0.000626	0.00121	CcSEcCtD
Paricalcitol—Dizziness—Vincristine—sarcoma	0.000625	0.00121	CcSEcCtD
Paricalcitol—Infestation NOS—Doxorubicin—sarcoma	0.000622	0.0012	CcSEcCtD
Paricalcitol—Infestation—Doxorubicin—sarcoma	0.000622	0.0012	CcSEcCtD
Paricalcitol—Urticaria—Etoposide—sarcoma	0.000608	0.00117	CcSEcCtD
Paricalcitol—Abdominal pain—Etoposide—sarcoma	0.000605	0.00117	CcSEcCtD
Paricalcitol—Body temperature increased—Etoposide—sarcoma	0.000605	0.00117	CcSEcCtD
Paricalcitol—Urinary tract infection—Doxorubicin—sarcoma	0.000605	0.00117	CcSEcCtD
Paricalcitol—Conjunctivitis—Doxorubicin—sarcoma	0.000605	0.00117	CcSEcCtD
Paricalcitol—Hypoaesthesia—Epirubicin—sarcoma	0.000601	0.00116	CcSEcCtD
Paricalcitol—Vomiting—Vincristine—sarcoma	0.000601	0.00116	CcSEcCtD
Paricalcitol—Pharyngitis—Epirubicin—sarcoma	0.000599	0.00116	CcSEcCtD
Paricalcitol—Sweating—Doxorubicin—sarcoma	0.000597	0.00115	CcSEcCtD
Paricalcitol—Urinary tract disorder—Epirubicin—sarcoma	0.000596	0.00115	CcSEcCtD
Paricalcitol—Rash—Vincristine—sarcoma	0.000596	0.00115	CcSEcCtD
Paricalcitol—Dermatitis—Vincristine—sarcoma	0.000595	0.00115	CcSEcCtD
Paricalcitol—Oedema peripheral—Epirubicin—sarcoma	0.000595	0.00115	CcSEcCtD
Paricalcitol—Connective tissue disorder—Epirubicin—sarcoma	0.000593	0.00115	CcSEcCtD
Paricalcitol—Urethral disorder—Epirubicin—sarcoma	0.000592	0.00114	CcSEcCtD
Paricalcitol—Headache—Vincristine—sarcoma	0.000592	0.00114	CcSEcCtD
Paricalcitol—Epistaxis—Doxorubicin—sarcoma	0.000587	0.00113	CcSEcCtD
Paricalcitol—Vomiting—Mitoxantrone—sarcoma	0.000585	0.00113	CcSEcCtD
Paricalcitol—Sinusitis—Doxorubicin—sarcoma	0.000584	0.00113	CcSEcCtD
Paricalcitol—Rash—Mitoxantrone—sarcoma	0.00058	0.00112	CcSEcCtD
Paricalcitol—Dermatitis—Mitoxantrone—sarcoma	0.00058	0.00112	CcSEcCtD
Paricalcitol—Headache—Mitoxantrone—sarcoma	0.000576	0.00111	CcSEcCtD
Paricalcitol—Eye disorder—Epirubicin—sarcoma	0.000564	0.00109	CcSEcCtD
Paricalcitol—Hypersensitivity—Etoposide—sarcoma	0.000564	0.00109	CcSEcCtD
Paricalcitol—Nausea—Vincristine—sarcoma	0.000561	0.00108	CcSEcCtD
Paricalcitol—Cardiac disorder—Epirubicin—sarcoma	0.00056	0.00108	CcSEcCtD
Paricalcitol—Hypoaesthesia—Doxorubicin—sarcoma	0.000556	0.00107	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—sarcoma	0.000554	0.00107	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—sarcoma	0.000552	0.00107	CcSEcCtD
Paricalcitol—Oedema peripheral—Doxorubicin—sarcoma	0.00055	0.00106	CcSEcCtD
Paricalcitol—Asthenia—Etoposide—sarcoma	0.000549	0.00106	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—sarcoma	0.000549	0.00106	CcSEcCtD
Paricalcitol—Angiopathy—Epirubicin—sarcoma	0.000548	0.00106	CcSEcCtD
Paricalcitol—Urethral disorder—Doxorubicin—sarcoma	0.000548	0.00106	CcSEcCtD
Paricalcitol—Nausea—Mitoxantrone—sarcoma	0.000546	0.00106	CcSEcCtD
Paricalcitol—Immune system disorder—Epirubicin—sarcoma	0.000545	0.00105	CcSEcCtD
Paricalcitol—Mediastinal disorder—Epirubicin—sarcoma	0.000544	0.00105	CcSEcCtD
Paricalcitol—Chills—Epirubicin—sarcoma	0.000542	0.00105	CcSEcCtD
Paricalcitol—Pruritus—Etoposide—sarcoma	0.000541	0.00105	CcSEcCtD
Paricalcitol—Arrhythmia—Epirubicin—sarcoma	0.000539	0.00104	CcSEcCtD
Paricalcitol—Alopecia—Epirubicin—sarcoma	0.000534	0.00103	CcSEcCtD
Paricalcitol—Mental disorder—Epirubicin—sarcoma	0.000529	0.00102	CcSEcCtD
Paricalcitol—Malnutrition—Epirubicin—sarcoma	0.000526	0.00101	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—sarcoma	0.000524	0.00101	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—sarcoma	0.000522	0.00101	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—sarcoma	0.000518	0.001	CcSEcCtD
Paricalcitol—Tension—Epirubicin—sarcoma	0.000516	0.000996	CcSEcCtD
Paricalcitol—Dysgeusia—Epirubicin—sarcoma	0.000515	0.000994	CcSEcCtD
Paricalcitol—Nervousness—Epirubicin—sarcoma	0.00051	0.000986	CcSEcCtD
Paricalcitol—Back pain—Epirubicin—sarcoma	0.000508	0.000982	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—sarcoma	0.000507	0.000979	CcSEcCtD
Paricalcitol—Dizziness—Etoposide—sarcoma	0.000506	0.000977	CcSEcCtD
Paricalcitol—Muscle spasms—Epirubicin—sarcoma	0.000505	0.000976	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—sarcoma	0.000505	0.000974	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—sarcoma	0.000503	0.000972	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—sarcoma	0.000501	0.000968	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—sarcoma	0.000499	0.000964	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—sarcoma	0.000494	0.000953	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—sarcoma	0.000489	0.000945	CcSEcCtD
Paricalcitol—Ill-defined disorder—Epirubicin—sarcoma	0.000488	0.000942	CcSEcCtD
Paricalcitol—Vomiting—Etoposide—sarcoma	0.000487	0.000939	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—sarcoma	0.000486	0.000939	CcSEcCtD
Paricalcitol—Anaemia—Epirubicin—sarcoma	0.000486	0.000938	CcSEcCtD
Paricalcitol—Agitation—Epirubicin—sarcoma	0.000483	0.000933	CcSEcCtD
Paricalcitol—Rash—Etoposide—sarcoma	0.000482	0.000932	CcSEcCtD
Paricalcitol—Dermatitis—Etoposide—sarcoma	0.000482	0.000931	CcSEcCtD
Paricalcitol—Headache—Etoposide—sarcoma	0.000479	0.000926	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—sarcoma	0.000477	0.000921	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—sarcoma	0.000476	0.000919	CcSEcCtD
Paricalcitol—Malaise—Epirubicin—sarcoma	0.000474	0.000915	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—sarcoma	0.000472	0.000912	CcSEcCtD
Paricalcitol—Vertigo—Epirubicin—sarcoma	0.000472	0.000912	CcSEcCtD
Paricalcitol—Syncope—Epirubicin—sarcoma	0.000471	0.00091	CcSEcCtD
Paricalcitol—Leukopenia—Epirubicin—sarcoma	0.00047	0.000908	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—sarcoma	0.00047	0.000908	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—sarcoma	0.000468	0.000903	CcSEcCtD
Paricalcitol—Palpitations—Epirubicin—sarcoma	0.000464	0.000897	CcSEcCtD
Paricalcitol—Loss of consciousness—Epirubicin—sarcoma	0.000462	0.000892	CcSEcCtD
Paricalcitol—Cough—Epirubicin—sarcoma	0.000459	0.000886	CcSEcCtD
Paricalcitol—Nausea—Etoposide—sarcoma	0.000455	0.000878	CcSEcCtD
Paricalcitol—Hypertension—Epirubicin—sarcoma	0.000454	0.000876	CcSEcCtD
Paricalcitol—Ill-defined disorder—Doxorubicin—sarcoma	0.000451	0.000871	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—sarcoma	0.000449	0.000868	CcSEcCtD
Paricalcitol—Chest pain—Epirubicin—sarcoma	0.000447	0.000864	CcSEcCtD
Paricalcitol—Myalgia—Epirubicin—sarcoma	0.000447	0.000864	CcSEcCtD
Paricalcitol—Arthralgia—Epirubicin—sarcoma	0.000447	0.000864	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—sarcoma	0.000447	0.000863	CcSEcCtD
Paricalcitol—Anxiety—Epirubicin—sarcoma	0.000446	0.000861	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000444	0.000858	CcSEcCtD
Paricalcitol—Discomfort—Epirubicin—sarcoma	0.000442	0.000854	CcSEcCtD
Paricalcitol—Malaise—Doxorubicin—sarcoma	0.000439	0.000847	CcSEcCtD
Paricalcitol—Dry mouth—Epirubicin—sarcoma	0.000438	0.000845	CcSEcCtD
Paricalcitol—Vertigo—Doxorubicin—sarcoma	0.000437	0.000844	CcSEcCtD
Paricalcitol—Syncope—Doxorubicin—sarcoma	0.000436	0.000842	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—sarcoma	0.000435	0.00084	CcSEcCtD
Paricalcitol—Confusional state—Epirubicin—sarcoma	0.000433	0.000835	CcSEcCtD
Paricalcitol—Palpitations—Doxorubicin—sarcoma	0.00043	0.00083	CcSEcCtD
Paricalcitol—Oedema—Epirubicin—sarcoma	0.000429	0.000828	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—sarcoma	0.000427	0.000825	CcSEcCtD
Paricalcitol—Infection—Epirubicin—sarcoma	0.000426	0.000823	CcSEcCtD
Paricalcitol—Cough—Doxorubicin—sarcoma	0.000424	0.000819	CcSEcCtD
Paricalcitol—Shock—Epirubicin—sarcoma	0.000422	0.000815	CcSEcCtD
Paricalcitol—Nervous system disorder—Epirubicin—sarcoma	0.000421	0.000812	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—sarcoma	0.00042	0.000811	CcSEcCtD
Paricalcitol—Skin disorder—Epirubicin—sarcoma	0.000417	0.000804	CcSEcCtD
Paricalcitol—Hyperhidrosis—Epirubicin—sarcoma	0.000415	0.000801	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—sarcoma	0.000414	0.000799	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—sarcoma	0.000414	0.000799	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—sarcoma	0.000414	0.000799	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—sarcoma	0.000413	0.000797	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000411	0.000794	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—sarcoma	0.000409	0.00079	CcSEcCtD
Paricalcitol—Anorexia—Epirubicin—sarcoma	0.000409	0.000789	CcSEcCtD
Paricalcitol—Dry mouth—Doxorubicin—sarcoma	0.000405	0.000782	CcSEcCtD
Paricalcitol—Hypotension—Epirubicin—sarcoma	0.000401	0.000774	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—sarcoma	0.0004	0.000773	CcSEcCtD
Paricalcitol—Oedema—Doxorubicin—sarcoma	0.000397	0.000766	CcSEcCtD
Paricalcitol—Infection—Doxorubicin—sarcoma	0.000394	0.000761	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000391	0.000755	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—sarcoma	0.00039	0.000754	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—sarcoma	0.000389	0.000752	CcSEcCtD
Paricalcitol—Insomnia—Epirubicin—sarcoma	0.000388	0.000749	CcSEcCtD
Paricalcitol—Skin disorder—Doxorubicin—sarcoma	0.000386	0.000744	CcSEcCtD
Paricalcitol—Paraesthesia—Epirubicin—sarcoma	0.000385	0.000744	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—sarcoma	0.000384	0.000741	CcSEcCtD
Paricalcitol—Dyspnoea—Epirubicin—sarcoma	0.000382	0.000738	CcSEcCtD
Paricalcitol—Somnolence—Epirubicin—sarcoma	0.000381	0.000736	CcSEcCtD
Paricalcitol—Anorexia—Doxorubicin—sarcoma	0.000378	0.00073	CcSEcCtD
Paricalcitol—Dyspepsia—Epirubicin—sarcoma	0.000378	0.000729	CcSEcCtD
Paricalcitol—Decreased appetite—Epirubicin—sarcoma	0.000373	0.00072	CcSEcCtD
Paricalcitol—Hypotension—Doxorubicin—sarcoma	0.000371	0.000716	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Epirubicin—sarcoma	0.00037	0.000715	CcSEcCtD
Paricalcitol—Fatigue—Epirubicin—sarcoma	0.00037	0.000714	CcSEcCtD
Paricalcitol—Pain—Epirubicin—sarcoma	0.000367	0.000708	CcSEcCtD
Paricalcitol—Constipation—Epirubicin—sarcoma	0.000367	0.000708	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000362	0.000698	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—sarcoma	0.000359	0.000693	CcSEcCtD
Paricalcitol—Paraesthesia—Doxorubicin—sarcoma	0.000356	0.000688	CcSEcCtD
Paricalcitol—Dyspnoea—Doxorubicin—sarcoma	0.000354	0.000683	CcSEcCtD
Paricalcitol—Feeling abnormal—Epirubicin—sarcoma	0.000353	0.000682	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—sarcoma	0.000353	0.000681	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Epirubicin—sarcoma	0.000351	0.000677	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—sarcoma	0.000349	0.000675	CcSEcCtD
Paricalcitol—Decreased appetite—Doxorubicin—sarcoma	0.000345	0.000666	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000343	0.000662	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—sarcoma	0.000342	0.000661	CcSEcCtD
Paricalcitol—Urticaria—Epirubicin—sarcoma	0.000341	0.000658	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—sarcoma	0.000339	0.000655	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—sarcoma	0.000339	0.000655	CcSEcCtD
Paricalcitol—Abdominal pain—Epirubicin—sarcoma	0.000339	0.000655	CcSEcCtD
Paricalcitol—Body temperature increased—Epirubicin—sarcoma	0.000339	0.000655	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—sarcoma	0.000327	0.000631	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000325	0.000627	CcSEcCtD
Paricalcitol—Hypersensitivity—Epirubicin—sarcoma	0.000316	0.00061	CcSEcCtD
Paricalcitol—Urticaria—Doxorubicin—sarcoma	0.000315	0.000609	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—sarcoma	0.000314	0.000606	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—sarcoma	0.000314	0.000606	CcSEcCtD
Paricalcitol—Asthenia—Epirubicin—sarcoma	0.000308	0.000594	CcSEcCtD
Paricalcitol—Pruritus—Epirubicin—sarcoma	0.000303	0.000586	CcSEcCtD
Paricalcitol—Diarrhoea—Epirubicin—sarcoma	0.000293	0.000567	CcSEcCtD
Paricalcitol—Hypersensitivity—Doxorubicin—sarcoma	0.000292	0.000565	CcSEcCtD
Paricalcitol—Asthenia—Doxorubicin—sarcoma	0.000285	0.00055	CcSEcCtD
Paricalcitol—Dizziness—Epirubicin—sarcoma	0.000284	0.000548	CcSEcCtD
Paricalcitol—Pruritus—Doxorubicin—sarcoma	0.000281	0.000542	CcSEcCtD
Paricalcitol—Vomiting—Epirubicin—sarcoma	0.000273	0.000527	CcSEcCtD
Paricalcitol—Diarrhoea—Doxorubicin—sarcoma	0.000272	0.000524	CcSEcCtD
Paricalcitol—Rash—Epirubicin—sarcoma	0.00027	0.000522	CcSEcCtD
Paricalcitol—Dermatitis—Epirubicin—sarcoma	0.00027	0.000522	CcSEcCtD
Paricalcitol—Headache—Epirubicin—sarcoma	0.000269	0.000519	CcSEcCtD
Paricalcitol—Dizziness—Doxorubicin—sarcoma	0.000262	0.000507	CcSEcCtD
Paricalcitol—Nausea—Epirubicin—sarcoma	0.000255	0.000492	CcSEcCtD
Paricalcitol—Vomiting—Doxorubicin—sarcoma	0.000252	0.000487	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—sarcoma	0.00025	0.000483	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—sarcoma	0.00025	0.000483	CcSEcCtD
Paricalcitol—Headache—Doxorubicin—sarcoma	0.000249	0.00048	CcSEcCtD
Paricalcitol—Nausea—Doxorubicin—sarcoma	0.000236	0.000455	CcSEcCtD
